Dolutegravir Monotherapy Possibly Boosted by Highly Active Natural Immunity

Clin Infect Dis. 2023 Oct 5;77(7):1021-1022. doi: 10.1093/cid/ciad365.
No abstract available

Publication types

  • Editorial
  • Comment